ELDON BIOLOGICALS A/S: Financial statements 2016
CVR: 26747007
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 6,073,914 and a net result of DKK 1,219,431 compared with DKK 1,501,774 the year before. That is an increase of 0.2% compared with the year before. Equity in the 2016 report amounted to DKK 1,271,623. The solvency ratio was 19.8%.
- Gross Profit
- DKK 6,073,914
- Profit/Loss
- DKK 1,219,431
- Equity
- DKK 1,271,623
- Total Assets
- DKK 6,407,394
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 6.1 mio. | 1.2 mio. | 1.3 mio. | - |
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Find more companies like ELDON BIOLOGICALS A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 13, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of ELDON BIOLOGICALS A/S.
As of September 13, 2016, REVISIONSFIRMAET SLEIMANN ApS has stepped down as auditor of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.